Skip to content

Payments to U.S. Health Care Professionals


Working with Health Care Professionals is essential to gaining the real-world information Valeant needs to deliver treatment choices that improve the health of patients.

Valeant interacts on a regular basis with Health Care Professionals for the purpose of informing them about Valeant's products, providing scientific and educational information and supporting medical education in an effort to benefit patients and enhance the practice of medicine.

In addition, Health Care Professionals have been very beneficial to Valeant in our goal to improve patients' lives. Health Care Professionals:

  • Participate in the research and development of life saving therapies and drugs.
  • Offer professional advice and consultation.
  • Lead educational forums with other healthcare professionals.
  • Participate in the exchange of information about Valeant products and therapies at their practices.

    • Valeant believes in compensating Health Care Professionals fairly for their bona fide services and strongly supports the transparency of such payments. Valeant does not offer payment to Healthcare Professionals for recommending or prescribing our products or as an inducement for promoting our products.

    Valeant's Payment Report allows you to view all individual payments made to Health Care Professionals or Healthcare Institutions. Health Care Professionals are listed in alphabetical order by first and last name or the name of the related institution.

    Payment to U.S. Healthcare Professionals in Q1 2011
    Payment to U.S. Healthcare Professionals in Q2 2011
    Payment to U.S. Healthcare Professionals in Q3 2011
    Payment to U.S. Healthcare Professionals in Q4 2011
    Payment to U.S. Healthcare Professionals in Q1 2010
    Payment to U.S. Healthcare Professionals in Q2 2010
    Payment to U.S. Healthcare Professionals in Q3 2010
    Payment Report not available for Q4, 2010 as a result of the merger between Biovail Corporation and Valeant Pharmaceuticals International which closed on September 28, 2010. Reporting to resume for Q1 2011.